Finnish biotech growth company Linio Biotech has announced a new investment round of EUR 4.2 million, bringing the company’s total financing to over EUR 9 million. In addition to previous family offices and private investors, Linio Biotech’s investors will now include new Finnish private investors and doctors familiar with the sector.
Linio Biotech’s Innovation is an Injectable Tissue Product Called Tience®
I have been following Linio Biotech’s journey closely for two years and it is inspiring to participate in the internationalisation of the excellent Tience® innovation. I have been working with fat and adipose stem cells for a long time and am familiar with their regenerative power.Linio’s new investor is Hilkka Peltoniemi, a plastic surgeon and surgical specialist doctor
Linio Biotech was founded in 2017 as a spin-off of the University of Tampere by co-founders Timo Ylikomi, professor of cell biology, and Riina Uusmies, cell biologist and researcher. It should be noted that Tience® products are manufactured in Tampere, Finland. Linio Biotech’s innovation is an injectable tissue product called Tience® (from the words tissue science). The product is intended for professional use only. It helps the skin to regenerate itself naturally by accelerating the natural healing process of the skin. Tience® treatment can be used to repair various skin imperfections such as signs of ageing or unwanted visible scars. Note for the new funding. It will help Linio Biotech to expand the availability of Tience® products and treatments. Tience® was launched in Finland in June 2023. It is also at the beginning of commercialisation in other Nordic countries.
We have seen very promising results with Tience® and with the new financing we can further develop our innovation and continue commercialisation towards international markets. Despite the challenging investment climate, the first phase of the investment round has been closed to enable the company to continue its ambitious roadmap.Karita Reijonsaari, CEO and partner of Linio Biotech